GUIDE FOR PATIENTS ON HIGH DOSES OF „VITAMIN“ D
(a thorough read on these recommendations is fundamental)
1
Cholecalciferol was mistakenly named as „vitamin (D) in the beginning of
XX when its presence was noticed in cod’s liver as substance with an
unknown chemical structure,
able to promote recovery and cure of children’s raquitism, promoting
absorption of calcium present in food (necessary for skeleton
development) providing, through this effect, the absorption of needed
amount of calcium for full skeleton development, without delay and
deformities caused by raquitism. Currently Cholecalciferol is not only
recognized as a steroidal substance (hormonal), but also as a necessary
substance for adjustment of 229 functions (genes) in all our cells. It is
primarily produced by exposure of the skin to the sun, and it is found only
in minimal quantities in foods, which are insufficient for the execution of
its numerous biological functions.
2
Lack of sun exposure due to a modern urban life (associated to
indiscriminate use of sun screens) led to an increase in occurrence of a
growing number of diseases that affect all the organs and systems of the
human body‘, where the most notorious ones are: infectious and
autoimmune illnesses, cancer, cardiovascular illnesses, hypertension,
diabetes, depression, autism, infertility, spontaneous miscarriages, and
pre-eclampsia.
3
„Vitamin“ D deficiency leads to loss of control of 229 functions (genes)
as well as in cells of the immune system, reducing the system’s potency
to fight infections and allowing immune aggression
against the organism. Individuals prone to develop autoimmune illnesses are
partially resistant to Vitamin D. Once they get ill, higher doses of
Cholecalciferol are needed in order to make the illness inactive, not only to
compensate this partial resistance, but also to „erase“ the false information
that part of the body must be seen as a micro-organism intruder by the
immunological system memory.
4
Contrary to what occurs with high doses of steroids and with the use of
immunosuppressive agents used as part of traditional treatment, the
administration of Cholecalciferol („vitamin“ D) increases the power of
Immunological system in combating
infections.
5
The use of higher doses of Cholecalciferol („vitamin“ D) is only viable
through prevention of its feared side-effect: the absorption of excessive
amounts of calcium present
in food. It’s like these higher doses of vitamin D „open completely thedoor“ to allow the passage of calcium from the interior of the bowel to the
blood stream, obliging the organism to get rid of excess calcium through urine
elimination. Calcium excess, concentrated during urine formation, could be
deposited in the kidneys, and could cause loss of renal function and make the
individual dependent on haemodialysis to survive.
6
To avoid renal lesion is fundamental that the patient does not ingest
calcium rich food (and „vegetable milks rich in calcium such as: soy, rice
or oat) as these foods cannot be present in the bowel when „the door“ to
the passage of calcium to blood is completely „open“ by „vitamin“ D in
higher doses. If there is not calcium excess in the other side of the door
(i.e. intestine’s interior), only the normal amount of calcium (present in
other foods) will pass to the blood flow (when the door is open by higher
doses of „vitamin“ D); and the elimination of excess calcium through
kidney is not necessary, which avoids risks to renal function and allows
patients to have a normal life, with no lesions or sequels (if these
sequels are not too old).
7
The patient should take special care with suppliers of vitamin D. Use
reliable compound chemists (specifically reliable in the manipulation of
„vitamin“ D) or industrialized product (Over the counter).
Doses above those prescribed ones (by manipulation mistake) can cause very
serious problems. On the other hand, if the compound chemist use expired
Cholecalciferol from stock, no beneficial effect will be obtained, and lots of
months of treatment will be wasted. Also during these months an aggression
of the immunological system against the organism will continue, with
consequent risk of cumulative sequels.
8
DIET: The recommended diet involves COMPLETE RESTRICTION of
dairy intake (foods that are integrally formed by milk, cheese, cheese
spread, yoghurt, curdled milk, cream of milk, caramel, milk pudding,
condensed milk) and of soy milk enriched with calcium (for reduction of the
amount of calcium ingested due to the use of high doses of vitamin D in your
treatment) . Foods that include milk in their preparation (mashed potato,
breads, cakes, biscuits, etc.), as well as butter and margarine, are liberated. It
is only advisable, but not mandatory, the restriction of poultry, meat and pork
meat (for reduction of the quantity of heterocyclic amines in the diet –
information on these substances are easily found by typing the expression
„heterocyclic amines“. It is recommended egg-vegetarian diet with fish, using
(as sources of protein) soy protein, tofu, egg white and fish (especially bred in
captivity to avoid the presence of high levels of mercury in the diet) which
should be preferably (but not invariably) prepared as stews or in steam as
sources of protein. What must be avoided: excessive consumption (routine) of
bananas, star fruit and anonaceas: sweet sop, sour sop and
atemoya. Recommended intake of raw green
leaves daily.
9
HYDRATION: Ingest high amounts of liquids (at least 2 and a half litres
of liquids daily, including water, juices,, soft drinks, teas, etc.). This
higher quantity of liquids assures a urine volume around
2.000 ml which allows calcium dilution eliminated in the urine, and avoids
excessive concentration of urinary calcium ( as when calcium is diluted it does
not get deposited in the kidney, preserving renal function).
10
INITIAL DOSE. The initial dose of „vitamin“ D to be administered
in the first appointment is calculated taking into consideration
various factors, especially patient’s weight and height, age, colour
of skin and seriousness of autoimmune manifestations. The most
fundamental functions to quality of life (i.e., vision, in case of MS)
influences the prescription of initial doses, and the doctor can opt
for an initial therapy including much higher doses.
11
Smoking worsens auto-immune diseases, and may reduce or
even undo the protective effect of high doses of „vitamin“ D. The
patient should quit smoking not to harm or even compromise
completely (undo) the effectiveness of your treatment.
12
For the same reason consumption of distillates should be avoided.
Limit consumption of alcohol to a glass of wine (or 2 cans of beer)
once a week. Alcohol inhibits the enzyme that converts
vitamin D to its active form (hormonal) and routine consumption of alcohol
limits the effectiveness of the treatment.
13
FAKE RELAPSE: „HEATED SCARS“. Every time a MS patient
with the disease in remission caused by the use of high doses of
vitamin D (Cholecalciferol) has emotional stress, or practices
exhausting physical exercises, or has sleep deprivation or is
submitted to excessive environmental heat, the patient may have
old symptoms (caused, for example, by a scar still present in their
nervous system) that return (on a milder way), and may occur in
the same place where it has previously occurred, or (if they had not
disappeared) may be intensified partially and temporarily. It is as if
emotional stress (or any of the other factors) „heats“ the scar. As
soon as the patient is calm, the symptoms start to cool down. If you
get stressed, afflicted, worried and think that you are having a new
relapse of the disease, you will extend the symptom.
14
A GENUINE NEW RELAPSE. A new relapse is generally
characterized by a new symptom, different, that has never
occurred. It is unlikely (not impossible) to have a new relapse after
the first 2 months of treatment with high doses of Cholecalciferol
that was prescribed, calculated (estimated) according to age,
weight and height. In rare cases in which this happens, it is verified
that it is the case of a mild relapse, identified then by the fact that
this is a new symptom, that has never occurred (or by a symptom
that has already occurred, but then occurs in an area of the body where it had not happened before), that sometimes gets spontaneously
resolved and that invariably does not leave sequels. Throughout the period in
which the dose of Cholecalciferol ( „vitamin“ D) is being adjusted, new
relapses may occur, which are treated in accordance with the traditional
procedure (pulse therapy with intravenous or oral corticosteroid, according to
its severity).
15
ADJUSTING THE DAILY DOSE OF CHOLECALCIFEROL
Adjusting the dose of vitamin D (Cholecalciferol) – according to the
specific needs of each patient – is done by the physician in the appointment (recommended after 2 months after start of treatment), through tests results comparison (blood and urine) collected before the start of the treatment (first round of tests) with the tests results (also blood and urine) collected during the treatment of at least 2months (second round of tests). Both pathology requests (containing acomplete tests list) are delivered to the patient or to the family member at thefirst appointment with the doctor. In other words, the interval between thebeginning of treatment and the collection of the second round of tests may notbe less than 2 months so that the adjustment calculation of daily doses for thepatient’s specific needs does not get compromised; during the first 2 monthsafter the treatment’s beginning or after the adjustment of Cholecalciferol dailydoses the vitamin D levels are not stabilized yet (they are still raising), thereforeblood and urine tests collection are not adequate before this period, except ifTHIRST happens, then test on calcium in the urine will be done independentlyfrom the other tests (SEE BELOW). On the other hand, you must allow at least
1 month from the last collection of tests until the appointment date for
evaluation of these tests to ensure that all the tests will be ready on the date of
the second appointment.
16
The maximum effect (which almost always represents the
remission of the disease) is reached after the course of 2 months
from the date of this adjustment (from the dose adjustment done in
the second appointment). Over the months until the maximum
effect is reached, disease relapses may still occur (in general they
are mild and of short duration), and must be treated with
intravenous pulse therapy or orally with steroids, according to the
severity of the manifestations.
17
During the period of adjustment of the final dose of „vitamin“ D,
the cooperation of the patient in seeking the maximum level of
calm is absolutely vital as relapses or exacerbations from
autoimmune diseases are in general (around 85% of cases)
triggered by emotional stress („stressing life occasions“). On the
other hand, the emotional stress level also influences the final
dose, and is often necessary to achieve higher levels of vitamin D
and an even more restricted diet in patients who remain
emotionally disturbed. If necessary, anti-depressants or
tranquillizers are used. Depression is knowingly facilitated by low
circulating levels of “vitamin“ D and it seems to be associated with
the progressive form of the disease, and should be appropriately
treated with antidepressants.
18
To make the adjustment of cholecalciferol doses ( „vitamin“ D) the
patient or their family member must check that all the required
tests have been made available by the pathology lab
and must bring the printed tests on the date of the appointment. It is not
recommended that the patient brings only a number of identification and a
password provided by the pathology lab for the secretary to try to access
results via internet on the occasion of the appointment. Often labs website
pages are congested by other patients internet access or your
medical centre may have internet problems, which don’tt
allow the adjustment
of the dose on the appointment date. When knowing that the tests will not be
available on the scheduled date for the appointment, the patient or their
family member should call the clinic in advance to postpone the
appointment’s date
19
The levels of vitamin D (25OHD3″ or “ 25-hydroxy-vitamin D‘) must
be high (above the reference values indicated as normal by the
pathology) from the second tests collection. That is
expected and it should not cause concerns. On the other hand, calcium levels
in the blood must be within normal limits if the patient is strictly observing the diet
and hydration recommended.
20
When ingested, the vitamin D (Cholecalciferol) should not be diluted
in juice or water (being insoluble in water, part of the dose would be
lost, stuck to the glass walls), nor dripped onto directly in the mouth
(to avoid eye-dropper contamination during accidental contact with
the oral mucous and the consequent growth of bacteria in the
solution, spoiling the expiry date of the preparation). The dose of the
solution to be ingested (measured with a dropper or with a syringe)
should be placed directly in a spoon and ingested on a pure form.
21
IN CASE OF TRAVEL. During the journeys, the non-encapsulated
form of Cholecalciferol (manipulated, diluted in sunflower oil) does
not need to be refrigerated, but should not be exposed
to heat (such as inside a car that was parked in the sun). On air plane trips the
vitamin D (Cholecalciferol) should be placed in checked baggage (in the
baggage compartment the temperature is low and the passenger does not need
to worry about the limit of liquids in hand luggage). When getting to your
destination, place it in the hotel’s refrigerator.
22
The use of nephrotoxic drugs must be avoided; they may limit the
elimination of calcium through the kidneys, accumulating in the
bloodstream, as „the door“ between the intestine and the blood
current is „open“ by higher circulating levels of „vitamin D. Avoid
taking unnecessary medications. Be especially careful with anti- inflammatory
drugs and antibiotics, especially administered by parenteral (intravenous or
intramuscular injection). If you are prescribed any medication as absolutely
necessary, read the leaflet and request information from the doctor and
pharmacist about its nephrotoxicity. If it is verified that the medication is in fact
nephrotoxic, discuss alternatives with the physician who has prescribed the drug.
If it is irreplaceable or absolutely necessary, hydration should be intensified to
reduce drug concentration as much as possible in the urine that is formed in the
kidneys Special care must be taken with parenteral antibiotics (such as the
aminoglycosides – intra-muscular or intra-venous) in case of serious respiratory
or urinary infections – these latter are common in patients prone to urinary
retention that are repeatedly using catheter to empty their bladder.
23
During the treatment, the patient should pay special
attention to the symptom of excessive thirst, because thirst
may indicate that the calcium is being eliminated in
excessive quantity in the urine, putting in risk the renal
function.
Firstly, the patient must differentiate the real thirst from „dry
mouth“ sensation, which can occur due to the low humidity of the
air, or in association with periods of stress, among other causes.
In the case of thirst the patient needs to consume a quantity of
liquids well above their standard to obtain relief of discomfort
(quench). In the „dry mouth“ case (which can occur, for example,
due to the low relative humidity of the air or temporarily in a
situation of emotional stress), the discomfort disappears with a
„wet“ mouth, not being necessary to swallow water. In case of
excessive and persistent thirst the patient has a need to take
several glasses of water to feel satiated.
24
As thirst may be caused by other factors (such as the intake of
salted foods, for example), there is no other way to clarify its cause
except through total calcium measure eliminated in the urine
collected over 24 hours ( “ 24-hour calcium urine test“) using one
of the forms that are provided by the physician on the occasion of
your appointment.
25
In the event of excessive THIRST (not „dry mouth“ ), the patient
should use the Calcium-Urine 24 hours form that was delivered
during their appointment and show it to the lab staff, who
will then supply a bottle for urine collection. Normally, the first urine is not used
(and eliminated in toilet), then all the urine over the next 24 hours must be
collected. While the urine is being collected, the daily dose of Cholecalciferol
should not be changed, because, if it is suspended or reduced (before or
during the collection of the urine) the result of the examination would no longer
represent what was occurring with the urinary calcium in response to daily
dose that was been taken.
26
When receiving the result of the 24-hour Calcium in the urine test
The patient (or family member) must calculate the concentration
of calcium in the urine, dividing the total quantity that was
eliminated in 24 hours by the volume of urine (in litres) that was
delivered to the lab. For example, assuming that the result of 24-hour
calcium in the urine test was of 400 mg per 24 hours, and that the
volume was 2,000 ml (equivalent to 2 litres) the value of
400mg is divided by 2 litres and the result of 200mg per litre
indicates that there is no risk to renal function, as it is below the
recommended maximum value (concentration).
27
The concentration of calcium in the urine is considered adequate
(i.e. the calcium is sufficiently diluted to the point of not causing
renal lesion) if it is
less than 250 mg per litre of urine (calculated through the 24-
Hour calcium urine test or verified through the isolated sample –
the latter associated with the weighing of geriatric diaper or
absorbent urinary pads changed over 24 hours – see below).
Abundant hydration (greater than or equal to 2 litres and a half of
liquid ingested over 24 hours) is essential to maintain the calcium
sufficiently diluted in the urine to the point of not causing renal
lesion.
28
If the calcium concentration is higher than 250 mg per litre of
urine, the patient should interrupt the daily doses of Cholecalciferol
for 3 days, which is usually the necessary time to obtain the
disappearance of excessive thirst. On the fourth day the patient should restart
taking a lower daily dose of vitamin D, as per medical recommendation.
29
It is possible that thirst (not the sensation of „dry mouth“) may
return after some days or some weeks following the reduction of
the vitamin D dose even if in the use of lower doses of
Cholecalciferol. In this case, the patient should repeat the Calcium
urine 24 hours test (without suspending the Cholecalciferol) and,
as the concentration of calcium in the urine exceeds again 250 mg
per Lire of urine, the patient should repeat what was recommended
in the previous item. Thus, suspending the daily administration of
Cholecalciferol for 3 days and restarting on the fourth day with a
once more reduced dose as per medical recommendation. It may
be necessary to lower the dose IF THIRST occurs again and IF the concentration of calcium in the urine is once more still higher than 250 mg per litre of urine.
30
In case of patients who have urinary incontinence and use
geriatric diaper or absorbent pads, a request form should be used
for Calcium in the urine in an isolated sample, where the
the absorbent pad (diaper) is simultaneously weighed at each change over the
course of 24 hours. The estimate of 24-hour Calcium urine test is made through
a calculation, where it is assumed that 1 kg of diaper or absorbent pad is
equivalent to 1 litre of urine. Thus, for example, if 4 pads were changed over 24
hours, weighing 550, 600, 450 and 700 grams, it is understood that the total
(2,300 grams) equals 2,300 ml = 2.3 litres. The total weight of diaper changed
over the 24 Hours may not be less than 2 kg if the patient is being properly
hydrated (ingesting a minimum volume 2 litre and a half of liquid per day).
Assuming that the concentration of calcium in isolated sample was 10 mg/dL
(10 mg per 100 ml), you will have eliminated 100 mg per litre (230 mg in2,3
litres of urine). As verified in the previous item, with this result the calcium is
sufficiently diluted in urine to the point of not causing renal injury.
31
Patients who present urinary urgency or incontinence reduce the
intake of liquids in order to minimize the occurrence of embarrassing
situations, such as having to leave suddenly in the midst of a meeting
at work, or during visits to family or friends in order to go to the toilet,
with the risk of not arriving in time to the toilet, and „wetting“ their
clothes (incontinence). The hydration (minimum intake of 2 litres and
a half of liquid over 24 hours), however, is non-negotiable, as it is
essential to protect renal function. Thus, it is recommended that the
patient seek urinating frequently and preventively. If going to a
meeting or visiting a shopping centre, you should try to urinate before
you leave. If you are in a meeting (or during a visit to the shopping
centre, or during a dinner or lunch out of the house) that can be
extended for a longer time than the usual interval between two
consecutive visits to the toilet, you must excuse yourself and go to the
toilet, before you feel any need to urinate, as a preventive measure to
empty urine as often as necessary, without prejudicing to the
recommended hydration.
32
The physician that monitors the patient can also prescribe
medication to reduce urinary urgency, and the schedules of these
medications can be settled in order to make that the maximum
effect coincides with outdoor lunch or dinner time (in restaurants or
at friends or family home) or in scheduled reunions. The effect of
one of the doses can also coincide with the hours of sleep at night
to reduce the frequency of visits to the toilet at night, which breaks
up sleep, and reduces quality of life. In some cases, a single
preventive visit to toilet during the night can avoid the use of night
time nappies (diaper) (or the patient can even avoid the discomfort
of having a wet nappy/diaper or absorbent pad). It is recommended
that the patient sets an alarm clock to be awake before being
under any urinary urgency (with the risk of having incontinence
before reaching the toilet). All these preventive measures can be
done in order to make recommended hydration viable.
33
Patients with neurogenic bladder, on the contrary, due to urinary
retention (and therefore even require repeated use of catheters to
empty the bladder) also are used to reduce ingestion of liquids as
a way to reduce the frequency of use of catheters. This habitcauses a great risk when they make use of high doses of Cholecalciferol,because the calcium that potentially is eliminated in excess in the urine
should be diluted to avoid being deposited in the kidneys, as already
emphasized in this text.
34On the other hand, periodically eliminating urine by spontaneous
contraction of the bladder is an important defence against
infections, because it is a mechanism that intermittently expels (sweeps) potential germ invaders out of the urinary tract. A patient with urinary retention has a mechanism already
impaired. If additionally the patient maintains the urine in the interior of the
bladder for a longer time due to a reduction (intentional) of liquid intake to reduce
the frequency of use of catheters, the patient provides the time necessary for
bacteria to multiply, and to transform the stagnated urine residue on the inside of
the bladder for long hours in an environment of bacterial culture. In addition, if it is
true that bladder catheterization can carry germs to the interior of the bladder, this
negative effect is probably supplanted by elimination of urine residue where
growing germs may be already present. This residue is then replaced by new urine
(newly formed). Maximum care should be taken in the perineum hygiene, with use
of antisepsis (anti-septic soap, appropriate anti-septic solution) and disposable
catheters. In addition, at each intestinal evacuation, the peri anal region should be
cleaned with anti-septic soap and hygienic douche (or, where this is not possible, if
you are not at home, with baby wipes moistened with antiseptic solution, sold inpharmacies). Most of the germs that cause urinary infections originate in microscopic waste faeces that are not eliminated by simple use of toilet paper;mixed with sweat, these germs are spread all over the perineum reaching the opening of urinary tract (urethra) and causing cystitis and pielonefritis.
35
If the urinary infection that is installed is sufficiently serious, the
patient may be hospitalized for use of potentially nephrotoxic
antibiotics intravenously, configuring the situation potentially
disastrous described in item “ 22″ of this text.
36
If preventive measures recommended here are not effective in the
prevention of recurrent urinary infections, patients with neurogenic
bladder caused by tendency of urinary retention may
discuss with a urologist about recommended local administration of botulinum
toxin
onto the urinary sphincter, allowing the spontaneous emptying of the bladder.
Even if this procedure causes a mild urinary incontinence (preferable to
urinary retention and multiple use of daily catheters, with a higher risk of
infections), the social constraints caused by incontinence can be avoided or
minimized through urinary absorbents use.
37
The recurrence of infections (respiratory, urinary or of any other
nature), when maintaining aggressiveness of the immune system,
affect the beneficial effect of high doses of Vitamin D in the disease control auto-immune The patient (woman) can,
additionally, chat with a gynaecologist to receive additional guidance to keep
sexual activity without triggering new urinary infections.
